This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated
Clinical trial NCT03315936 · COMPLETED
Trial details
- NCT number
- NCT03315936
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-02
- Primary completion
- 2018-09-10
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.